Authors


William Barany, PharmD

Latest:

Candida Auris: The Rise of a New Fungal Threat

Candida auris—Are we prepared for another multidrug-resistant pathogen?


LACEY AVERY, MA

Latest:

Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report

A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.


J. NICHOLAS O

Latest:

Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract Infections

Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.


EMILY HEIL, PHARMD, BCPS-AQ ID

Latest:

Globalization of Antibiotic Stewardship Programs: The World Is Waiting

The globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.


Shirley M. Mueller, MD

Latest:

Suffering through COVID-19: A Doctor's Personal Journey

Frontline health care workers had a nearly 12 times higher risk of testing positive for COVID-19 compared with individuals in the general community.


LUCIA ROSE, PHARMD

Latest:

Hospital-Acquired and Ventilator-Associated Pneumonia: Highlights and Pitfalls of the 2016 IDSA / ATS Guidelines

Hospital-acquired and ventilator-associated pneumonia account for 22% of all hospital-acquired infections.



Christina G. Rivera, PharmD, BCPS

Latest:

ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT Patients

This In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.


KAITE KAMMERS, PHARMD, BCPS

Latest:

Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis

Invasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.


YASIR AL-KHALILI, MD

Latest:

Searching for the Cause of Hearing Loss in a Patient With HIV

Early diagnosis and treatment were essential to ensuring a good prognosis.


Joseph DeRose, DO

Latest:

Doravirine: Researchers DRIVE for a Drug Ahead of Its Class

A novel NNRTI hits the market, but what place will it have in treatment?


Amanda Warren

Latest:

Aging HIV-Infected Population Faces Unique Challenges

As the population of people living with HIV infection is living longer, age-related health issues are affecting these individuals in an accelerated or emphasized fashion.


Glenn S. Tillotson, PhD, FIDSA, FCCP

Latest:

Reviewing Real-World Cases of C diff Biotherapeutic

Here is a brief report of 5 cases of the use of fecal microbiota, live-jslm (Rebyota) in the management of recurrent Clostridioides difficile infection.



MICHAEL P. VEVE, PHARMD

Latest:

Considerations for Aerosolized Antibiotics in Multidrug-Resistant Gram-Negative Pneumonia

Aerosolized antibiotics are a reasonable adjunctive option to treat multidrug-resistant gram-negative pneumonia due to excellent pulmonary concentrations and few adverse effects.


Anita Ko, MD

Latest:

Final Diagnosis: Disseminated Kaposi Sarcoma With Tonsillar and Pulmonary Involvement

A shocking find on a CT scan leads to an unexpected diagnosis.


AMY FORRESTEL, MD

Latest:

Never Ignore a New Rash in a Patient With AIDS

A case of Kaposi sarcoma with immune reconstitution inflammatory syndrome.


Yoav Golan, MD

Latest:

ABSSSI and OPAT: Key Messages

Panelists hypothesize on theoretical downsides of resistance development for gram-negative infections and reflect on the importance of implementing outpatient parenteral antibiotic therapy.



Milena McLaughlin, PharmD, MSC, BCPS-AQ ID, AAHIVP

Latest:

Undetectable Equals Untransmittable

A breakthrough message for patients that must be delivered correctly by health care providers. The Undetectable Equals Untransmittable, or U=U, move­ment is a global campaign definitively stating that people living with HIV (PLWH) who have undetectable HIV RNA are unable to transmit HIV. By educating people, the hope is that they will get tested and, if necessary, start and stay on treatment. This message has been endorsed by many organizations, including the US Centers for Disease Control and Prevention and the HIV Medicine Association.




Evan Loh, MD, Chief Executive Officer, Paratek Pharmaceuticals

Latest:

Antibiotic Resistance: Challenges and Opportunities for Treating Serious Bacterial Skin Infections

As current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.



RAVINDRA SANGITHA, MD

Latest:

Salt, Ticks, and Lyme: A Case of Lyme Neuroborreliosis Presenting as SIADH

This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).


Christian Sandrock, MD, MPH, FCCP

Latest:

Key Takeaways on Managing Antimicrobial Resistant Gram-Negative Infections

Christian Sandrock, MD, MPH, FCCP, shares key takeaways on the antimicrobial resistant gram-negative infection space from ID week 2023.



Liza Vaezi, MSc, Pharm D, BCPS-AQID

Latest:

Carriage of ESBL-PE May Increase the Risk of Colorectal Surgical Site Infections

Is it time to screen for these bacteria and modify colorectal surgical prophylaxis?



William R. Short, MD, MPH

Latest:

An Unusual Case of Testicular Swelling in a Patient With HIV

Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.

© 2024 MJH Life Sciences

All rights reserved.